Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
James T. Parsons Insider Profile
4 Followers
James T. Parsons, Director at Diamedica Therapeutics, holds 59.94K shares in Diamedica Therapeutics (Ticker: DMAC), holds 0.00 shares in Trillium Therapeutics (Ticker: TRIL).
James T. Parsons has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of James T. Parsons's holdings
Insider Roles
Director
Roles that James T. Parsons holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by James T. Parsons
James T. Parsons's Trading History
Diamedica Therapeutics
Jan 02, 2024
Director
Uninformative Buy
60.00K
$261.92K
Trillium Therapeutics
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see James T. Parsons's performance on stock
You May Also Like
James T. Parsons insider profile FAQ
What is the percentage of profitable transactions made by James T. Parsons?
The percentage of profitable transactions made by James T. Parsons is ―.
What is the average return per transaction made by James T. Parsons?
The average return per transaction made by James T. Parsons is ―.
What stocks does James T. Parsons hold?
James T. Parsons holds: DMAC, TRIL stocks.
What was James T. Parsons’s latest transaction?
James T. Parsons latest transaction was an Uninformative Buy of $60.00K.
What was James T. Parsons's most profitable transaction?
James T. Parsons’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is James T. Parsons's role in Diamedica Therapeutics?
James T. Parsons's role in Diamedica Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.